Nuclear Imaging

Videos | Nuclear Imaging

Rob Beanlands, M.D., FASNC, 2019 American Society of Nuclear Cardiology (ASNC) president, shares a couple trends he sees ...

Home November 07, 2019
Home
Videos | Nuclear Imaging

Robert C. Hendel, M.D., explains some of the new cardiac radiotracers in the pipeline that were discussed in sessions at ...

Home November 06, 2019
Home
Philips Medical System is recalling its older Forte Gamma Camera SPECT imaging systems due to the possibility of the detectors falling off of the unit onto the patient. The two gamma cameras can bee seen in this photo on either side of the patient bed. These can be rotated above the patient.
Feature | Molecular Imaging | Dave Fornell, Editor

November 5, 2019 — Philips Medical System is recalling the Forte Gamma Camera System due to the potential for the 660 ...

Home November 05, 2019
Home
Videos | PET-CT

Rupa Sanghani, M.D., FASNC, associate professor, Rush Medical College, director of nuclear cardiology and stress ...

Home October 30, 2019
Home
Videos | Cardiac Diagnostics

Clyde Yancy, M.D., MSc, cardiology chief and vice dean for diversity and inclusion at Northwestern University, Feinberg ...

Home October 29, 2019
Home
News | Cardiac Imaging

September 9, 2019 — The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along ...

Home September 09, 2019
Home
News | Radiopharmaceuticals and Tracers

August 2, 2019 — The American Society of Radiologic Technologists (ASRT) announced its support for House Resolution (HR) ...

Home August 02, 2019
Home
With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a costly tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. The image shows how SPECT allows the reader to distinguish between blood pool activity and radiotracer uptake.
Feature | Nuclear Imaging | Christopher A. Hanson M.D., and Jamieson M. Bourque M.D., MHS

Cardiac amyloidosis is a highly morbid and underdiagnosed infiltrative cardiomyopathy that is characterized by the ...

Home July 22, 2019
Home
News | Radiopharmaceuticals and Tracers

July 16, 2019 – NorthStar Medical Radioisotopes LLC  announced completion of construction on its 20,000-square-foot ...

Home July 16, 2019
Home
News | Cardiac Imaging

June 7, 2019 — The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best ...

Home June 07, 2019
Home
News | Radiopharmaceuticals and Tracers

June 5, 2019 – BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), introduced a novel ...

Home June 05, 2019
Home
News | Radiopharmaceuticals and Tracers

May 17, 2019 — Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular ...

Home May 17, 2019
Home
News | Radiopharmaceuticals and Tracers | Jeff Zagoudis, Associate Editor

May 10, 2019 — Shine Medical Technologies Inc. broke ground on their first medical isotope production facility in ...

Home May 10, 2019
Home
A comparison of the first photo of a black hole (left) and a nuclear myocardial perfusion exam. This imaging is also referred to as nuclear cardiology, molecular imaging, nuclear heart scan, PET, SPECT cardiac exam.
Feature | Dave Fornell, Editor, and A.J. Connell

May 1, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) maga ...

Home May 01, 2019
Home
Subscribe Now